Company Encyclopedia
View More
name
Nutex Health
NUTX.US
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health.
181.75 B
NUTX.USMarket value -Rank by Market Cap -/-

Financial Score

20/11/2025 Update
B
Health Care FacilitiesIndustry
Industry Ranking9/22
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE37.82%A
    • Profit Margin7.11%B
    • Gross Margin53.35%B
  • Growth ScoreA
    • Revenue YoY187.10%A
    • Net Profit YoY248.71%A
    • Total Assets YoY99.11%A
    • Net Assets YoY310.72%A
  • Cash ScoreA
    • Cash Flow Margin1405.98%B
    • OCF YoY187.10%A
  • Operating ScoreA
    • Turnover1.25A
  • Debt ScoreD
    • Gearing Ratio59.94%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Viking Holdings shares are trading higher after the company reported better-than-expected Q3 financial results.

    benzinga_article·
    US
    VIK
    +1.94%
    benzinga_article·
    US
    VIK
    +1.94%

    Earnings Momentum Lifts PACS And Nutex; Zynex And Genenta Also Advance After Hours

    Several stocks, including PACS Group and Nutex Health, saw significant after-hours trading movements due to earnings announcements and financing updates. PACS reported a substantial increase in net income and revenue, while Nutex reversed a previous net loss with a strong revenue rise. Zynex and Genenta also experienced notable stock movements, despite no new announcements. Ekso Bionics gained after-hours following a recent direct offering disclosure.

    rttnews·
    US
    NUTX
    +33.69%
    US
    PACS
    +54.19%
    rttnews·
    US
    NUTX
    +33.69%
    US
    PACS
    +54.19%

    Nutex Health Q3 Net Income USD 96.799 Million

    Nov 19 (Reuters) - Nutex Health Q3 EBIT USD 130.367 million. * Q3 pretax profit USD 123.939 million * Q3 gross profit USD 154.881 million

    Reuters·
    US
    NUTX
    +33.69%
    Reuters·
    US
    NUTX
    +33.69%

    NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS | NUTX Stock News

    Nutex Health reported significant financial growth for the first nine months of 2025, with total revenue increasing by 225.5% to $723.6 million compared to 2024. Net income reached $59.0 million, reversing a loss from the previous year. EBITDA and adjusted EBITDA saw substantial increases, driven by the hospital division's performance. The company also reported strong operating income and cash flow, with total assets of $964.5 million as of September 30, 2025.

    StockTitan·
    US
    NUTX
    +33.69%
    StockTitan·
    US
    NUTX
    +33.69%

    Nutex Health Q3 revenue beats expectations

    Nutex Health's Q3 revenue grew 239.9% year-over-year, beating analyst expectations with $267.8 million. The company reported a net income of $55.4 million, reversing a loss from Q3 2024, and regained Nasdaq compliance. Hospital division revenue increased 262.8%. The stock has a median 12-month price target of $220.00, 54.9% above its recent closing price. The current analyst rating is 'buy'.

    Reuters·
    US
    NUTX
    +33.69%
    Reuters·
    US
    NUTX
    +33.69%